Literature DB >> 7875198

p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.

A Poggi1, N Pella, L Morelli, F Spada, V Revello, S Sivori, R Augugliaro, L Moretta, A Moretta.   

Abstract

Four monoclonal antibodies (mAb) termed NKTA255, NKTA72, 1F1 and 1B1 were selected on the basis of their ability to inhibit the cytolytic activity of natural killer (NK) cell clones against P815 target cells. These mAb selectively reacted with normal or tumor cells of hematopoietic origin and displayed a cellular distribution similar to that of CD45 or CD11a/CD18 antigens. Immunoprecipitation experiments showed that they reacted with molecules with an apparent molecular mass of 40 kDa under both reducing and nonreducing conditions ("p40" molecules), thus differing from CD45 or CD11a/CD18 antigens as well as from the "inhibitory" receptors for HLA class I molecules (i.e. p58, CD94 and NKB1 molecules). Double-immunofluorescence analysis of peripheral blood mononuclear cells allowed the identification of three distinct populations on the basis of the fluorescence intensity of cells stained with anti-p40 mAb. p40bright cells were homogeneously HLA-DR-positive, p40medium cells were HLA-DR-negative but co-expressed CD56 antigens, while p40dull cells were all CD3+. Anti-p40 mAb strongly inhibited the lysis of K562 target cells, mediated by fresh NK cells, as well as the lysis of P815 target cells by NK or T cell clones. In addition, in redirected killing assays, anti-p40 mAb strongly reduced the anti-CD16 mAb-induced cytolytic activity of NK cell clones. On the contrary, they did not inhibit either the anti-CD3 or anti-T cell receptor mAb-mediated cytolytic activity of T cell clones or the lysis of allogeneic phytohemagglutinin blasts mediated by specific cytolytic T cell clones. The p40-induced inhibition of the NK cytotoxicity required optimal cross-linking, as anti-p40 mAb could inhibit the lysis of Fc gamma receptor (Fc gamma R)-positive but not of Fc gamma R-negative target cells. In addition, (Fab')2 fragments of anti-p40 mAb failed to inhibit the lysis of Fc gamma R-positive target cells. In conclusion, p40 molecules represent a new type of inhibitory surface molecule that appears to play a general regulatory role in the NK-mediated cytolysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875198     DOI: 10.1002/eji.1830250210

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Identification and characterization of the rat homologue of LAIR-1.

Authors:  Robert Jan Lebbink; Talitha de Ruiter; Guido J A Kaptijn; Linde Meyaard
Journal:  Immunogenetics       Date:  2005-05-18       Impact factor: 2.846

2.  U5 monoclonal antibody identifies a novel lymphocyte surface antigen preferentially expressed in human circulating natural killer cells with high cytotoxic activity.

Authors:  S Ikura; K Terao; I Matsuzaki; M Inoue-Murayama; Y Murayama
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

3.  The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.

Authors:  Irene Bonaccorsi; Claudia Cantoni; Paolo Carrega; Daniela Oliveri; Gabrielle Lui; Romana Conte; Michele Navarra; Riccardo Cavaliere; Elisabetta Traggiai; Marco Gattorno; Alberto Martini; Maria Cristina Mingari; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

4.  Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.

Authors:  Barbara M Colombo; Paolo Canevali; Ottavia Magnani; Edoardo Rossi; Francesco Puppo; Maria Raffaella Zocchi; Alessandro Poggi
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

5.  CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.

Authors:  M Exley; S Porcelli; M Furman; J Garcia; S Balk
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

6.  Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells.

Authors:  M Falco; R Biassoni; C Bottino; M Vitale; S Sivori; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

7.  Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1.

Authors:  Lijun Xu; Shanlong Wang; Jufeng Li; Jie Li; Bingyu Li
Journal:  Oncoimmunology       Date:  2020-04-07       Impact factor: 8.110

Review 8.  NK cell autoreactivity and autoimmune diseases.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2014-02-04       Impact factor: 7.561

Review 9.  Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.

Authors:  Xunlei Kang; Jaehyup Kim; Mi Deng; Samuel John; Heyu Chen; Guojin Wu; Hiep Phan; Cheng Cheng Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 10.  Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer.

Authors:  Simona Sivori; Mariella Della Chiesa; Simona Carlomagno; Linda Quatrini; Enrico Munari; Paola Vacca; Nicola Tumino; Francesca Romana Mariotti; Maria Cristina Mingari; Daniela Pende; Lorenzo Moretta
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.